ASPIRUS KEWEENAW HOSPITAL — History
CCN 231319 | 3-year financial timeline | COVID resilience: 51/100
🛡️ Public data only — no PHI permitted on this instance.
$59M
Latest Revenue (FY2022)
+4.7%
Revenue CAGR (3yr)
-12.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $54M | $58M | $59M | +1.7% | +4.7% |
| Operating Expenses | $59M | $64M | $67M | +4.4% | +6.0% |
| Operating Margin | -10.1% | -9.9% | -12.9% | -30.0% | +0.0% |
| Net Income | $-5M | $-6M | $-8M | -32.2% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 3,270 | 4,155 | 3,730 | -10.2% | +6.8% |
| Medicare Day % | 31% | 30% | 30% | +2.2% | -1.7% |
| Medicaid Day % | 3% | 2% | 2% | -35.7% | -26.1% |
COVID Impact & Recovery
Resilience Score: 51/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +9.7% ($54M → $59M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.7%
This Hospital
+7.6%
State Avg
Latest Margin
-12.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $62M | -14.2% |
| FY2024 (proj) | $64M | -15.6% |
| FY2025 (proj) | $67M | -17.0% |